story of the week
Autologous Stem Cell Transplantation After Alemtuzumab in Aggressive MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Autologous Hematopoietic Stem Cell Transplantation Following Alemtuzumab Therapy in Aggressive Multiple Sclerosis: A Report of Three Cases
Mult. Scler. 2020 Aug 25;[EPub Ahead of Print], G Boffa, E Sbragia, AM Raiola, R Varaldo, E Capello, P Gallo, F Granella, G Mancardi, M IngleseFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.